Mersana Therapeutics's market cap is currently $65.23M. The company's EPS TTM is $-0.613; its P/E ratio is ―; Mersana Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 36.85M	$ 26.58M	$ 43.00K	$ 828.00K	$ 42.12M
Gross Profit	$ -111.41M	$ 25.65M	$ -131.97M	$ -66.21M	$ -12.92M
Operating Income	$ -170.96M	$ -204.69M	$ -169.71M	$ -87.69M	$ -29.22M
EBITDA	$ -166.08M	$ -199.96M	$ -167.94M	$ -86.68M	$ -26.73M
Net Income	$ -171.67M	$ -207.54M	$ -169.21M	$ -88.40M	$ -27.20M
Balance Sheet
Cash & Short-Term Investments	$ 209.08M	$ 280.71M	$ 177.95M	$ 255.09M	$ 99.79M
Total Assets	$ 226.06M	$ 334.34M	$ 206.11M	$ 273.40M	$ 107.54M
Total Debt	$ 33.83M	$ 36.30M	$ 38.18M	$ 16.57M	$ 7.76M
Net Debt	$ -140.73M	$ -244.41M	$ -139.77M	$ -238.52M	$ -54.59M
Total Liabilities	$ 189.16M	$ 242.28M	$ 84.37M	$ 45.31M	$ 29.22M
Stockholders' Equity	$ 36.90M	$ 92.06M	$ 121.74M	$ 228.09M	$ 78.32M
Cash Flow
Free Cash Flow	$ -171.05M	$ -51.56M	$ -140.64M	$ -75.17M	$ -68.35M
Operating Cash Flow	$ -168.88M	$ -49.36M	$ -139.99M	$ -74.70M	$ -67.74M
Investing Cash Flow	$ 119.88M	$ -152.72M	$ -648.00K	$ 37.03M	$ -27.29M
Financing Cash Flow	$ 94.67M	$ 153.02M	$ 63.65M	$ 230.41M	$ 97.70M

Currency in USD

Mersana Therapeutics Earnings and Revenue History

Income Statement >

Mersana Therapeutics Debt to Assets

Balance Sheet >

Mersana Therapeutics Cash Flow

Cash Flow >

Mersana Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing